facebook
twitter
rss
account
search
search
 

First new lupus drug in 50 years

March 10, 2011 at 6:12 PM   |   Comments

LA JOLLA, Calif., March 10 (UPI) -- The drug Benlysta, or belimumab, has been approved by the U.S. Food and Drug Administration to treat the most common type of lupus.

Dr. Richard A. Lerner, president of Scripps Research, said Benlysta, developed by GlaxoSmithKline and Human Genome Sciences, is the first new drug treatment for lupus in 50 years.

"I am deeply gratified that our scientific findings have proven so valuable to drug discovery," Lerner said in a statement. "This development underlines the importance of basic academic science in laying important groundwork for life-saving medical advances."

The drug is approved for systemic lupus erythematosus -- a chronic, life-threatening inflammatory disease affecting the joints, skin, kidneys, blood, heart and lungs.

Benlysta targets a specific protein -- B-lymphocyte stimulator -- involved in stimulating the "autoantibodies" causing lupus and certain other autoimmune disorders, Lerner said.

© 2011 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Most Popular
1
Mom recovering after emergency surgery to save quadruplets Mom recovering after emergency surgery to save quadruplets
2
Morning exercise helps calm ADHD symptoms in children Morning exercise helps calm ADHD symptoms in children
3
Yoga guru BKS Iyengar dies at 95 Yoga guru BKS Iyengar dies at 95
4
Childhood depression may be lessened with music therapy, study finds Childhood depression may be lessened with music therapy, study finds
5
31,000 pounds of gluten-free chicken products recalled 31,000 pounds of gluten-free chicken products recalled
Trending News
Around the Web
x
Feedback